Piperidine derivatives as histamine H3 receptor ligands

Details for Australian Patent Application No. 2005267932 (hide)

Owner AstraZeneca AB

Inventors Hamley, Peter; Hunt, Simon Fraser; Wesolowski, Steven; Folmer, James

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005267932

PCT Pub. Number WO2006/014136

Priority 0401971-7 02.08.04 SE

Filing date 27 July 2005

Wipo publication date 9 February 2006

International Classifications

C07D 211/58 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61K 31/4523 (2006.01) - containing further heterocyclic ring systems

A61K 31/497 (2006.01)

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/014136 Priority application(s): WO2006/014136

25 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005267933-A method and a device for safeguarding a horse in a transport

2005267931-Novel piperidine derivatives as histamine H3 receptor ligands for treatment of depression